🧬 Staying Focused During Biotech Funding Ups & Downs | Roy Maute (Part 4/4)

Episode notes

The Biotech Startups Podcast is powered by Excedr —helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science. As a TBSP listener, you can get exclusive perks through Excedr’s partner network—special savings, promotions, and more. Explore these offers today: . “This is where the real scientific innovation and the impact meet. So for me, it's the most exciting type of opportunity to have, and I'm not looking anywhere else.” In this episode of The Biotech Startups Podcast, we follow Roy Maute ’s journey from the Gilead acquisition of Forty Seven Inc. through COVID-era corporate life—where he spent over a year at Gilead without meeting colleagues in person—to co-founding Pheast Therapeutics in 2021, clarifying his passion for early-stage company building.